Status:

COMPLETED

Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Cancer

Pulmonary Embolism

Eligibility:

All Genders

21+ years

Brief Summary

The purpose of this study is to see if a blood test (D-dimer) is as precise as the CT scan for the detection of clots. A pulmonary embolism is an obstruction of the blood vessels in your lungs usuall...

Eligibility Criteria

Inclusion

  • All patients evaluated in the urgent care center and determined to need with CT pulmonary angiogram to rule out pulmonary embolism based on signs and symptoms such as dyspnea, pleuritic chest pain, tachycardia, and/or pulse oxygen desaturation will be included.

Exclusion

  • Inability to obtain CT pulmonary angiogram secondary to lack of IV access, contrast allergy or lack of consent.
  • CT pulmonary angiogram not done with routine protocol for rule out pulmonary embolism.
  • Less than 21 years of age

Key Trial Info

Start Date :

May 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2008

Estimated Enrollment :

213 Patients enrolled

Trial Details

Trial ID

NCT00615147

Start Date

May 1 2005

End Date

June 1 2008

Last Update

January 9 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Memorial Sloan-Kettering Cancer Center

New York, New York, United States, 10065